If you’ve ever worked in process development, biotech scale-up, or specialty chemicals, you know that a pilot plant is where lab discoveries stop being just ink on paper and start becoming something real. You run a pilot plant supplier, so I’m guessing you’ve been on both sides of this: the excitement when a client’s bench-top reaction looks like it could move to scale, and the slow, frustrating conversations that come when that same client realizes there’s more to piloting than building a small reactor. One of the biggest landmines those conversations hit? Legal issues. Most first-time pilot plant operators (and even veteran ones) don’t walk into a project understanding just how many legal boxes need to be checked before the first drop of product even runs, and as a supplier, it’s your job to not just deliver equipment, but help your clients avoid the mess that comes from cutting corners on compliance. Pilot Plants
Let’s start with intellectual property, because that’s the number one issue I see playing out again and again. A lab scientist might develop a compound in a university fume hood, keeping their formula tucked in a notebook or a cloud drive. But when you move that process to a pilot plant, you’re not just making small batches—you’re capturing detailed data about yield, temperature variance, side reactions, and even the specific materials that work better than the generic ones mentioned in a patent. Last year, I worked with a startup that was developing a new biodegradable polymer. They came to us ready to build their pilot unit, and they had only filed a provisional patent on their core monomer. What they didn’t realize was that when they shared process parameters with us (and with their on-site engineering team), they were disclosing know-how that wasn’t covered by the provisional. We had to walk them through a non-disclosure agreement (NDA) that went beyond our standard contract: not just protecting their core formula, but the detailed piloting data, the specific catalyst they’d be using, and even the layout of their pilot unit, because competitors could reverse-engineer the process from that data.
The risk here is twofold. First, if your client doesn’t have a clear IP agreement with you, they might not own the pilot plant’s process data at all. If your contract only says you’re selling equipment, not services, and you’re doing process development alongside the build, you could hold that data as your own. Second, if your client is working with academic partners or contract research organizations (CROs), the terms of that partnership might mean they don’t own the piloting IP either. I once had a client whose university had retained rights to any process developed using their lab facilities, so when that client tried to license their pilot plant tech later, they couldn’t because the university still claimed a stake. As a supplier, I always include a clause in our contracts that clarifies IP ownership for process data generated during our work, and I’ll even help draft simple addendums to NDAs if our client is working with third parties—because if they mess up IP, our equipment is useless to them.
Next up is environmental and regulatory compliance, and this is where a lot of clients get blindsided. A pilot plant isn’t just a mini version of a full-scale factory, and the rules that apply to both are completely different. For example, in the U.S., the Environmental Protection Agency (EPA) regulates pilot plants under the Clean Air Act and Clean Water Act, but the thresholds for reporting emissions or wastewater discharges are far lower for piloting than for full production. Wait, no—actually, the reverse: some regulations don’t apply to pilot plants at all, but others have stricter requirements for piloting because of the novelty of the process. I had a specialty chemical client a few years ago that skipped checking their state’s environmental rules, because they thought “it’s just a pilot, not a commercial plant.” They were running a reaction that produced a volatile organic compound (VOC) that wasn’t present in their lab, because at full scale, they’d be adding a different solvent. Their local environmental agency showed up after a neighbor complained about a strange smell, and they were fined $12,000 before they even ran their second batch.
The rules don’t stop at the EPA. If your client is working with hazardous materials, OSHA (Occupational Safety and Health Administration) has specific standards for pilot plant personnel, even if the plant only runs a few hours a week. For biotech clients, the FDA has guidelines for pilot-scale cell culture and biomanufacturing, and if the pilot plant is intended to support a clinical trial, the data generated there has to be compliant with 21 CFR Part 11 (electronic records) and Part 210 (current good manufacturing practices). I’ve had to push back on clients who try to cut corners here—like using a basic database instead of a validated LIMS (Laboratory Information Management System) for biotech data, because they think it’s a pilot, not a commercial manufacturing facility. If that data is going to be used to file an IND (Investigational New Drug) application, a regulator will reject it if the LIMS isn’t compliant, and that delays a client’s entire project by months. As a supplier, we now include a regulatory compliance assessment as part of our pilot plant design process. We don’t just build skids and reactors—we map out the data collection systems and safety controls that will meet the client’s local, state, and federal rules, and we’ll even provide guidance on which permits they need to apply for, because if their pilot plant isn’t permitted, they can’t operate it.
Then there’s the issue of liability, which is the legal area that hits suppliers and clients hardest when something goes wrong. Let’s say a pilot plant reactor fails, releasing toxic fumes or causing an explosion. Who’s responsible? If your client didn’t properly maintain the equipment you supplied, or if they modified it without your approval, that’s one thing. But if you designed the reactor to their specifications, and the specs were wrong? That’s a lawsuit waiting to happen. A few years back, I worked with a client who wanted to build a pilot plant for a high-pressure hydrogenation reaction. They gave us a set of specifications for the reactor’s pressure rating, but they forgot to mention that their process would have pressure spikes 20% higher than the standard they’d used. We built the reactor to their specs, and during the first run, a seal failed, spilling hydrogen into the facility. No one was hurt, but the client had to shut down for two weeks, and they sued us for $500,000 in lost revenue. We ended up settling because our contract didn’t have a clear clause about verifying process limits beyond the client’s specifications.
Now, as a supplier, I’ve learned to build those verification steps into our process, but liability goes both ways. If your client violates safety rules on-site, that’s a legal risk for you too, because many commercial general liability policies cover “operations of the site” regardless of who is in charge. I now require all of our pilot plant clients to provide proof of general liability insurance before we deliver any equipment, and our contracts include clear clauses that outline what modifications are allowed (none, without written approval) and what safety protocols the client must have on-site. We also limit our liability for indirect damages—like lost revenue from a shutdown—to the total cost of the equipment we supplied. That’s a standard clause, but it’s one that a lot of new clients push back on, until they learn the hard way that lawsuits don’t care if you’re a startup with a tight budget.
There’s also a less talked about legal issue when it comes to insurance and risk transfer. A lot of pilot plant operators assume that their standard business insurance will cover their site, their employees, and any third parties working there. But pilot plants, especially those handling novel or hazardous materials, are often categorized as higher risk than regular office space or even lab facilities. I once had a client whose insurance company refused to cover their pilot plant after a near-miss with a chemical leak, because the plant wasn’t registered as a “commercial process facility.” That left the client on the hook for all costs related to the leak, which ran into six figures. As a supplier, we now provide our clients with a detailed list of insurance requirements tailored to their pilot plant—what types of coverage they need, how much they should carry, and what exclusions they should look out for. We also work with a small network of insurance providers who specialize in process development facilities, because most general insurers don’t understand the unique risks of a pilot plant.
Wait, let’s not forget about contract terms that are specific to pilot plants, not to full-scale projects. A pilot plant is a temporary, experimental facility, so the terms of use are different. For example, if a client is renting our pilot plant equipment (some suppliers offer rental, not just purchase, for clients who only need it for a few months of piloting), the rental agreement has to clarify what happens if the pilot run goes longer than expected. Does the rental rate go up? Are there penalties for delays? I once had a client who rented our equipment for three months, because their lab work said the process would take 60 days. But when they hit a side reaction that took four months to resolve, they tried to renegotiate the rental rate, claiming the delay was our fault because the equipment wasn’t “flexible enough.” Our rental agreement had a clause that said any extensions beyond the initial term would be billed at a higher rate, and that modifications to the process that caused delays were the client’s responsibility, so we didn’t lose money on that.
Another contract-related legal issue is change orders. Pilot plant projects almost always change—clients realize they need a different reactor size, or they add a new safety system, or they adjust their process parameters mid-build. If the change order isn’t documented properly, that can lead to disputes about cost, timeline, and liability. I had a client a few years ago who asked us to add a cryogenic cooling system to their pilot plant after we’d already ordered all the components for the standard cooling system. We added the cryo system, but we never signed a formal change order, so when we sent them the invoice for the extra $80,000, they claimed it was a “free upgrade” and refused to pay. We ended up having to take them to small claims court, which cost us time and money that we could have avoided if we’d just made the change order part of our process. Now, every request for a change, no matter how small, has to be written, signed, and added to the original contract before we do any work. That’s a tedious step, but it’s saved us from hundreds of thousands of dollars in disputes.
Let’s circle back to IP one more time, because it’s the issue that affects both suppliers and clients most in the long run. A client might come to me and say, “We just need a pilot plant to test our process, no one else will ever see the data.” But the data from a pilot plant is what they’ll use to get funding, to file patents, and to license their technology. If their IP isn’t protected, a competitor can take that data, build their own pilot plant, and steal their market. As a supplier, I’m not a lawyer, but I give my clients access to templates for NDAs, patent addendums, and IP clauses, and I always recommend that they work with a patent attorney who specializes in process development. I’ve had clients skip that step, and within a year, they were trying to sue a former CRO that had seen their pilot data, because the CRO had filed a similar patent. That’s a avoidable legal mess, and it starts with the right agreements before any equipment is purchased.
At the end of the day, running a pilot plant supplier means we wear a lot of hats: engineer, project manager, and sometimes, legal guide. The legal issues around pilot plants aren’t just red tape—they’re what separate a successful scale-up from a costly, delayed project. IP disputes, regulatory fines, liability lawsuits, and contract disputes can make or break a client, and they can hurt our business too, because word travels fast in process development circles. If you’re looking to build or scale a pilot plant, don’t wait until you have a near-miss or a dispute to start thinking about these issues. Work with a supplier who understands not just reactors and skids, but the legal landscape that comes with piloting new processes. To learn how we can tailor a pilot plant solution to meet your compliance, IP, and liability needs, reach out to our team to discuss your project requirements today.
Pressure Vessels References
U.S. Environmental Protection Agency. (2022). Pilot Plant Emission and Wastewater Reporting Thresholds. EPA Office of Compliance.
Occupational Safety and Health Administration. (2021). Process Safety Management for Pilot-Scale Facilities. OSHA 3807-10.
U.S. Food and Drug Administration. (2023). Guidance for Industry: Pilot Scale Biomanufacturing for Human Drugs and Biologics. FDA Center for Drug Evaluation and Research.
American Bar Association. (2020). Intellectual Property in Process Development and Pilot Plant Projects. ABA Science and Technology Section.
National Fire Protection Association. (2022). NFPA 45: Standard on Fire Protection for Laboratories Using Chemicals, Pilot Plant Addendum.
Weihai Chemical Machinery Co., Ltd.
Weihai Chemical Machinery Co., Ltd. is one of the leading pilot plants manufacturers and suppliers in China. We warmly welcome you to buy OEM pilot plants from our factory. All customized products are with high quality and low price. For quotation, contact us now.
Address: Dongxin Road No.9, Zhangcun Town, Huancui District, Weihai City, China
E-mail: sales@weihaicm.com
WebSite: https://www.weihaicm.com/
